Home | Stories & News | Post
- June 24-26, 2026
- Max Delbrück Center for Molecular Medicine (BIMSB), Berlin
Building Bridges: Joint Berlin–Jerusalem Symposium for Cancer Research and Clinical Oncology
From 24 to 26 June 2026, 146 researchers, clinicians, institutional leaders and students gathered in Berlin for the Joint Berlin–Jerusalem Symposium for Cancer Research and Clinical Oncology. The meeting marked an important step towards closer cooperation between leading cancer research and clinical oncology centres in Berlin and Jerusalem.
Combining scientific exchange, support for early-career researchers and historical reflection, the symposium laid the foundation for future collaboration in research, education and patient care.
Connecting Berlin and Jerusalem
The symposium brought together participants from Charité – Universitätsmedizin Berlin, the Berlin School of Integrative Oncology, the Max Delbrück Center for Molecular Medicine, the Hebrew University of Jerusalem and Hadassah Medical Center.
The scientific program took place over two days at the Max Delbrück Center and featured five thematic sessions and ten keynote lectures by internationally recognised experts. The sessions covered precision oncology, cancer genomics, immuno-oncology, tumour biology and the tumour microenvironment, as well as palliative and patient care.
Presentations by both senior scientists and younger researchers encouraged exchange across disciplines and career stages. They also helped identify complementary areas of expertise between the participating institutions, including immunotherapy and cellular therapy, precision radiotherapy, advanced genomics, and artificial intelligence and machine learning.
Supporting the Next Generation
Early-career researchers were at the heart of the symposium. Of the 146 participants, 78 were students or early-career scientists, and 40 presented their own research.
Their contributions included 30 oral presentations and 20 posters from German and Israeli institutions. Four poster presentations received awards for scientific excellence.
GIF fully supported the participation of 17 Israeli students and early-career researchers, enabling them to travel to Berlin, present their work and connect with leading scientists, clinical experts and potential future collaborators.
Networking sessions and social events created further opportunities for young researchers to discuss their ideas, receive feedback and establish professional relationships. These encounters may lead to joint projects, shared supervision, exchange programmes and further career-development opportunities.
Reflecting on History & Responsibility
The final day at Charité Mitte placed the scientific partnership within its broader historical context.
A lecture by Anna von Villiez explored the experiences of Jewish physicians in Germany before, during and after the Second World War. Participants also joined a tour organised through the GeDenkOrt.Charité memorial project, which commemorates the victims of National Socialist medical crimes.
These activities provided space to reflect on the history connecting Germany and Israel and on the ethical responsibilities that continue to shape cooperation in medicine and science today.
From Scientific Exchange to Lasting Cooperation
Beyond the scientific program, institutional leaders and heads of oncology met to discuss the development of a long-term partnership between Berlin and Jerusalem.
Participants identified several promising areas for future cooperation, including translational and clinical cancer research, student education and training, and exchanges for physician-scientists and clinical fellows.
Plans for further collaboration include:
- Joint translational and clinical research projects
- Binational and European funding applications
- Student, trainee and faculty exchanges
- Clinical fellowships and mobility programmes
- Regular scientific forums and institutional meetings
The next steps will involve developing formal collaboration agreements, initiating the first joint projects and establishing regular leadership meetings to coordinate future activities.
A Foundation For the Future
The symposium demonstrated how scientific excellence can serve as the basis for broader and more sustainable institutional cooperation. Its most important outcome is the network it created: connecting researchers across disciplines, institutions and career stages in Berlin and Jerusalem.
By combining scientific exchange with mentorship, historical reflection and strategic planning, the meeting laid a strong foundation for collaborations that can advance cancer research and ultimately contribute to improved patient care.
The symposium was supported by the German–Israeli Foundation for Scientific Research and Development (GIF), Stiftung Charité and the Embassy of Israel in Berlin, with organisational support from the Max Delbrück Center Communications Team and the Berlin School of Integrative Oncology.
Related Posts
Scientific Exchange Symposium: Prevention, Resilience, and Innovation: New Paradigms for Mental and Brain Health
The third Charité–Clalit Scientific Exchange Symposium brought together researchers from Clalit Health Services, Charité and...
READ MORE »Job Vacancy – Student Position – Data Management & CRM (Microsoft Dynamics 365)
GIF - the German Israeli Foundation for Scientific Research & Development (www.gif.org.il) seeks to fill...
READ MORE »Building Bridges: Joint Berlin–Jerusalem Symposium for Cancer Research and Clinical Oncology
The Joint Berlin-Jerusalem Symposium for Cancer Research & Clinical Oncology brought together 146 researchers, clinicians...
READ MORE »